首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >CA-1 method, a novel assay for quantification of normal prothrombin using a Ca2+ -dependent prothrombin activator, carinactivase-1.
【24h】

CA-1 method, a novel assay for quantification of normal prothrombin using a Ca2+ -dependent prothrombin activator, carinactivase-1.

机译:CA-1方法,一种使用Ca2 +依赖性凝血酶原激活剂carinactivase-1定量测定正常凝血酶原的新方法。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We established a novel prothrombin assay, designated CA-1 method, for quantification of normal prothrombin in application of a Ca2+ -dependent prothrombin activator, carinactivase-1 (CA-1), found in the venom of Echis carinatus leucogaster. On microplate, thrombin converted from normal prothrombin in plasma sample by CA-1 cleaves a thrombin specific chromogenic substrate, t-butoxy-Val-Pro-Arg-p-nitroanilide and liberates p-nitroaniline. Then, the normal prothrombin level is decided by measuring the velocity of p-nitroaniline liberation. Normal prothrombin levels in plasma from warfarin-treated individuals were highly correlated with coagulant activities assayed by both prothrombin time and thrombotest. CA-1 method is not only a rapid and highly sensitive chromogenic microplate assay for quantification of normal prothrombin in the range of 10-200 ng/100 microl in plasma samples but also suitable for analyses of many samples in a short time. In addition, normal prothrombin levels obtained by CA-1 method are not inhibited by EDTA and heparin, which reduce prothrombin time and thrombotest activities. CA-1 method is a novel assay for monitoring coagulant activity in warfarin-treated individuals.
机译:我们建立了一种新的凝血酶原测定法,称为CA-1方法,用于定量应用在棘皮leu虫蛇毒中的Ca2 +依赖性凝血酶原激活剂carinactivase-1(CA-1)来定量正常凝血酶原。在微孔板上,通过CA-1从血浆样品中的正常凝血酶原转化而来的凝血酶裂解了凝血酶特异性发色底物t-丁氧基-Val-Pro-Arg-对硝基苯胺并释放了对硝基苯胺。然后,通过测量对硝基苯胺释放的速度来确定正常的凝血酶原水平。华法林治疗个体血浆中的正常凝血酶原水平与凝血酶原时间和血栓试验测定的凝血活性高度相关。 CA-1方法不仅是一种快速,高度灵敏的生色微孔板测定法,用于定量测定血浆样品中正常凝血酶原的浓度,范围为10-200 ng / 100 microl,还适用于短时间内对许多样品进行分析。此外,通过CA-1方法获得的正常凝血酶原水平不受EDTA和肝素的抑制,从而减少了凝血酶原时间和血栓形成活性。 CA-1方法是一种新方法,可用于监测华法林治疗的个体中的凝血活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号